You do not have subscription access to articles in this section. Learn more about access.

  JoVE Biology

You do not have subscription access to articles in this section. Learn more about access.

  JoVE Neuroscience

You do not have subscription access to articles in this section. Learn more about access.

  JoVE Immunology and Infection

You do not have subscription access to articles in this section. Learn more about access.

  JoVE Medicine

You do not have subscription access to articles in this section. Learn more about access.

  JoVE Bioengineering

You do not have subscription access to articles in this section. Learn more about access.

  JoVE Engineering

You do not have subscription access to articles in this section. Learn more about access.

  JoVE Chemistry

You do not have subscription access to articles in this section. Learn more about access.

  JoVE Behavior

You do not have subscription access to articles in this section. Learn more about access.

  JoVE Environment

You do not have subscription access to articles in this section. Learn more about access.

  JoVE Developmental Biology


 JoVE Biology

Studying Age-dependent Genomic Instability using the S. cerevisiae Chronological Lifespan Model

1, 1, 1

1Andrus Gerontology Center, Department of Biological Sciences, Department of Molecular and Computational Biology, University of Southern California, Los Angeles

    Downloads Comments Metrics


    Here we describe a set of DNA mutation assays that can be combined with the yeast chronological life span model to study the genes/pathways that regulate or contribute to genomic DNA instability during aging.

    Date Published: 9/29/2011, Issue 55; doi: 10.3791/3030

    Cite this Article

    Wei, M., Madia, F., Longo, V. D. Studying Age-dependent Genomic Instability using the S. cerevisiae Chronological Lifespan Model. J. Vis. Exp. (55), e3030, doi:10.3791/3030 (2011).


    Studies using the Saccharomyces cerevisiae aging model have uncovered life span regulatory pathways that are partially conserved in higher eukaryotes1-2. The simplicity and power of the yeast aging model can also be explored to study DNA damage and genome maintenance as well as their contributions to diseases during aging. Here, we describe a system to study age-dependent DNA mutations, including base substitutions, frame-shift mutations, gross chromosomal rearrangements, and homologous/homeologous recombination, as well as nuclear DNA repair activity by combining the yeast chronological life span with simple DNA damage and mutation assays. The methods described here should facilitate the identification of genes/pathways that regulate genomic instability and the mechanisms that underlie age-dependent DNA mutations and cancer in mammals.


    Two lifespan models have being used to study aging in S. cerevisiae: RLS and CLS. The replicative (budding) life span (RLS) is based on the observation that yeast mother cells undergo a finite number of divisions3-6. We will focus on the chronological lifespan (CLS), a model based on the chronological survival of non-dividing yeast in culture or on plates7-11.Wild type yeast grows exponentially for 10-12 hours in synthetic dextrose complete (SDC) medium. When glucose level reduces, yeast switches from fermentation to respiration, a process termed diauxic shift. Cells continue to divide slowly during the post-diauxic phase for approximately 48 hours before entering G0 arrest. The metabolic rate of the cells remains high till day 5-6 (day 0 is the inoculation day). Cell viability over time can be accessed by the percentage of the chronologically aging cells, sampled every two days, which can exit G0 arrest and form colonies on rich YPED plates.

    1. Yeast chronological lifespan (CLS) in liquid culture

    1. Inoculate a single colony into 1 ml synthetic complete glucose medium (SDC, Table 1) and incubate overnight with shaking (220 rpm) at 30°C. Three inoculums from independent colonies should be prepared for each strain to provide biological replicas.
    2. Dilute the overnight culture into fresh SDC medium (usually 10 ml) to OD=0.05-0.1 (˜1:100 dilution) and incubate with shaking (220 rpm) at 30°C. This time point is considered day 0 of the chronological aging. Maintain a 1:5 ratio of culture/flask volume (10 ml culture in 50 ml, or for longer/large experiments 25 ml culture in 125 ml) to ensure proper aeration.
    3. Starting from day 3, remove 2 aliquots of 10 μl from the flask, dilute 10,000 times in autoclaved water, 10 μl diluted culture (i.e., 104-10) on YEPD (1% yeast extract, 2% bacto peptone, 2% dextrose, 2% agar) plates, and incubate at 30°C for 48-72 hours before colony forming unite (CFU) is counted.
    4. Day 3 CFU is considered 100% survival. Dilution factors of aging culture in the subsequent days should be adjusted accordingly to ensure ˜20-100 colonies in the CFU assay (e.g., 104-10, 104-30, 103-10, etc.). For wild type cells in the DBY746 background, the CLS reaches 1% survival around day 11.

    Variations of in situ viability assay include:

    • Calorie restriction (CR) by glucose limitation. Dilution of overnight culture in glucose limited SC medium (such as 0.5 or 0.05% instead of the standard 2% glucose) generally lead to lower population saturation density on day 3, but much extended mean and maximal (10% survival) lifespan12.
    • For extreme CR/starvation, wash the day 3 stationary phase culture (usually 10 ml, as in step 3 above) with autoclaved water (resuspend cells in equal volume of water and spin down at 2500 rpm for 5 min, repeat 3 times). Incubationof cells in water mimics the starvation condition that yeast may encounter in the wild. Every two days subsequently, aging culture should be washed with autoclaved water and resuspended in equal volume of water to remove any nutrients released from lysed dead cells. Perform viability assay by sampling the aging culture as described above. This starvation condition will led to almost a doubling of mean CLS in the wild type DBY746 strain12.

    2. in situ viability assay

    In the liquid culture, a small fraction of the surviving cells may re-entered the cell cycle and grow utilizing remaining nutrients or those released form lysed dead cells in the medium, a phenotype termed regrowth/gasping13. We developed a viability-on-a-plate system that utilizes the auxotrophy of the DBY746 strain (trp1)to circumvent the regrowth/gasping problem and also allow the testing of the effect of constant exposure or deprivation of various external nutrients or stimuli on yeast CLS11. This in situ viability assay also mimics the replicative lifespan model such that cells are constantly exposed to abundant nutrients for the duration of the lifespan analysis.

    1. Inoculate a single colony into 1 ml synthetic complete glucose medium (SDC) and incubate overnight with shaking (220 rpm) at 30°C. At least three inoculums from independent colonies should be prepared for each strain to provide biological replicas.
    2. Let the culture to grow to ˜108 cells/ml (OD600=˜10), dilute the culturewith autoclaved water to 100-200 cell/10 μl (usually 104-fold dilution) and 1,000 cells/10 μl (103-fold dilution).
    3. Plate two aliquots of 10-30 μl of diluted culture onto one tryptophan dropout SDC plate. For each strain, prepare a set of 8 to 20 plates and labeled according to plating density(e.g., 104-fold diluted, plate 10 μl or 104-10, 104-30, 103-10, 103-30, etc.), which ensure 10-100 colonies can be counted in anticipation of decreased viability during aging.
    4. Incubate the plate set at 30°C for the duration of the lifespan analysis.
    5. On the day of plating and every 2 days subsequently, remove one plate and drop-wise add 0.5 ml Tryptophan (2 mg/ml) to allow viable cells to grow. Incubate the plate at 30°C for additional 48-72 hours. Count the CFU for viability on the day of tryptophan addition. The CFU on the day of plating is considered 100% survival.

    Variations of in situ viability assay include:

    • Age cells on agar plates (extreme starvation condition). Add 1 ml 2x YPED instead of tryptophan on subsequent days to allow growth and CFU count14.
    • Age cells on plates with tryptophan dropout synthetic complete medium with various carbon sources, e.g. various concentrations of glucose (calorie restriction by glucose limitation), various carbon sources such as ethanol, glycerol, acetic acid14. Add 1 ml glucose/tryptophan solution (20% glucose and 1mg/ml tryptophan) to allow growth and CFU count.
    • Other nutrient manipulation, such as nitrogen.

    3. DNA damage and mutation frequency during chronological aging

    Canavanine resistance (Canr) and can1 sequencing
    Spontaneous mutation frequency can be evaluated by measuring the frequency of canavanine resistance (Canr) in chronologically aging cultures. Mutations in the CAN1 (YEL063) gene, which encodes the plasma arginine permease, render cells resistant to the arginine analogue L-canavanine.Canr colonies collected at different time points can also be saved for extraction of genomic DNA and subsequent sequencing of the CAN1 gene, which can provide mutation spectrum data (with Mutation Surveyor, SoftGenetics).

    Base substitutions (Trp+ reversions)

    Strains with trp1-289 contain an amber mutation (C403T) in the TRP1 coding sequence. Measurement of frequency of trp1-289 to Trp+ reversion15 allows the estimation of base substitution rate during yeast chronological aging.

    Frame-shift mutations

    The Lys- strain EH150 (MATa, lys2ΔBglII, trp1-Δ, his3-Δ200, ura3-52, ade2-1o) harbors a lys2ΔBglII mutation that was constructed by inserting 4 nucleotides to create a BglII restriction enzyme site in the LYS2 gene. The resulting +4 shift in the open reading frame results in auxotrophy for lysine that can be reversed by small insertion/deletion mutations16-17.

    Gross chromosomal rearrangements (GCRs)

    To detect gross chromosomal rearrangements (GCRs), we generated a mutant strain, in which HXT13 (YEL069), encoding a highly redundant hexose transporter, was disrupted by a URA3 cassette18. HXT13 is located 7.5 kb telomeric to CAN1 on chromosome V. Mutations in both CAN1 and URA3 genes render cells resistance to L-canavanine and 5-fluoroorotic acid (5FOA), respectively. Considering the low frequency of point mutations that occur in both genes, analysis of the Canr 5FOAr frequency provides an estimation of GCRs that result in the loss of both genes.

    Homologous and homeologous recombination

    To monitor the level of homologous (100%) and homeologous recombination (91%) during chronological aging, we generated mutants in which linearized plasmids (HIS3::intron-IR-URA3) carrying either 100% homologous inverted repeats (IRs) (pSR406) or 91% homeologous IRs (pSR407) at the HIS3 locus19. Recombination between the IRs allows the expression of functional His3 protein.

    1. In parallel to normal viability assay (as described above), remove an appropriate amount of cells from the aging culture,
      1. for Canr mutation, start with ˜2x107 cells (200 μl of day 3 culture);
      2. for Trp+ reversion, start with ˜108 cells (500-1000 μl of day 3 culture);
      3. for Lys+ frame-shift mutation, start with ˜108 cells (500-1000 μl of day 3 culture);
      4. for GCRs, start with 2-3x108 cells (2-3 ml of day 3 culture);
      5. for homologous and homeologous recombination, start with ˜5x107 cells (200-500 μl of day 3 culture);
      adjust the plating amount according to the decrease in total viability and the increase in mutation frequency during chronological aging (Table 2). In case of strains with hypermutator phenotype (such as those with deficiencies in DNA repair), reduce the sampling amount accordingly.
    2. Pellet the cells with bench-top centrifuge machine (6000 rpm for 5 min).
    3. Resuspend cells in 1 ml autoclaved water, and pellet the cells again.
    4. Resuspend cell pellet in 100 μl of water. Plate cells,
      1. for Canr mutation, on arginine-dropout synthetic complete medium plates (SDC-Arg, supplemented with 60 μg/ml L-canavanine sulfate);
      2. for Trp+ reversion, on tryptophan-dropout plates (SDC-Trp);
      3. for Lys+ frame-shift mutation, on lysine-dropout plates (SDC-Lys);
      4. for GCRs, on arginine-dropout plates (SDC-Arg)supplemented with 5FOA (1 mg/ml) and L-canavanine sulfate (60 μg/ml);
      5. for homologous and homeologous recombination, on histidine-dropout plates supplemented with galactose (2%).
    5. Count CFUs after 3-4 days' incubation at 30°C. The mutation frequency is normalized to the number of viable cells.

    Complementary to the in situ viability assay, age-dependent Trp+ reversion, Lys+ frame-shift mutation, recombination, or Canr can also be studied in cells aged on plate.

    1. Plate cells (˜108 cells/plate) on to Trp-, Lys-, His-dropout, or L-canavanine synthetic complete medium plates (as described above).
    2. Every two days (or at the time point of interest), score the newly emerging colonies.
    3. Mutation frequency is estimated by normalizing newly emerging colonies to the total number of viable cells of the specific day.

    4. Translesion synthesis (TLS)

    The age-dependent mutation frequency increase may involve increased macromolecule damage, diminished cellular protection/repair, and increased erroneous DNA repair (such as Polζ-dependent translesion synthesis, TLS) during aging. For example, the long-lived sch9Δ mutants exhibit elevated expression of SOD2, and decreased expression of the error-prone DNA repair enzyme Rev120. Here we describe an assay combining damaged DNA template and whole nuclear extract to evaluate the TLS in vitro.

    1. Prepare nuclear extract as described by Wang et al.21; quantify the protein concentration by BCA assay (Pierce).
    2. Add 0, 5, 10 or 20 μg of nuclear extracts to 50 μl (final volume) reactions containing TLS Buffer (20 mM HEPES, 7 mM MgCl2, 1 mM DTT, 25 mM NaCl, pH 7.8), 200 μMdNTPs and 100 nM 5'-32P-labelled 12-mer primer (5'-CGA TGG TAC GGA-3') annealed to a 48-mer template containing DNA damage of interest (5'-TCG ATA CTG GTA CTA ATG ATT AAC GAC TXA AGC ACG TCC GTA CCA TCG-3', in which X is the damaged site, e.g., abasic site, 8-oxo-G, etc.).
    3. Incubate the mixture at 30°C for 30 min, terminate the reaction with the addition of 2.5 μl EDTA (20 mM) and 2 μl of proteinase K (10 mg/mL).
    4. Purify DNA with phenol extraction and ethanol precipitation.
    5. Resuspend DNA in 50 μl of gel loading buffer (98% formamide, 20 mM EDTA, and dye).
    6. Resolve the translesion synthesis products on 19% polyacrylamide gels.
    7. Quantify the TLS using phosphorimaging (Figure 1).

    5. Representative Results

    We typically used the CFU counts on day 3 as 100 percent survival in the standard liquid CLS analysis. The percentage survival in the subsequent days can be fitted to calculate the mean (50% survival) and maximum (10% survival) life spans12. Life span results obtained from the in situ viability assay are generally consistent with those using the liquid CLS assay, but with reduced the mean life span, which is due in part to the fact that cells are constantly exposed to nutrients. Presence of glucose inhibits the activity of cellular protection as showed by the reduced transactivation of stress response transcription factor such as Msn2/4 and Gis112.

    Age-dependent mutation frequency varies greatly depending on the strain background, genetic manipulation, culture conditions, and age. Table 2 shows the typical results obtained in the wild-type strain (DBY746).

    Component g/L
    D-glucose 20
    Ammonium sulfate 5
    Nitrogen base (-AS/-AA) 1.8
    NaH2PO4 1.4
    Adenine 80
    L-Arginine 40
    L-Aspartic acid 100
    L-Glutamic acid 100
    L-Histidine 80
    L-Isoleucine 60
    L-Leucine 120
    L-Lysine 60
    L-Methionine 80
    L-Phenylalanine 60
    L-Serine 400
    L-Threonine 200
    L-Tryptophan 80
    L-Tyrosine 40
    L-Valine 150
    Uracil 80

    Table 1. Synthetic complete glucose medium, SDC (adjust to pH 6.0 with NaOH). 4-fold excess of histidine, leucine, tryptophan, and uracil are included to compensate the auxotrophy of the DBY746 strain.

    Day 3 (mean ± SEM) Up to (during aging)
    Canr 1.76 ± 0.12 x10-6 6-8 x10-6
    Trp+ reversion 6.60 ± 1.70 x10-8 1.60 x10-6
    Lys+ frame-shift mutation 3.00 ± 0.78 x10-8 0.70 x10-6
    GCRs 0.62 ± 0.10 x10-8 0.30 x10-6
    Homologous recombination 5.55 ± 2.74 x10-6 27.00 x10-6
    Homeologous recombination 0.12 ± 0.04 x10-6 0.48 x10-6

    Table 2.Typical mutation frequencies of wild type cells (DBY746) during chronological aging.

    Figure 1
    Figure 1. Result of translesion synthesis (TLS)20. Nuclear extracts from 3 day-old stationary phase wild-type (DBY746) and sch9Δ mutant cells were incubated with undamaged or abasic site-containing DNA templates for 30 min at 30°C. TLS products are indicated by solid (with undamaged template) or dotted (with damaged template) lines. There was no translesion synthesis observed in nuclear extract from sch9Δ mutants. Free primers are indicated by the open arrow.


    Liquid aging cultures sometime exhibit regrowth/gasping phenotype13, which complicates the CLS analysis. Regrowth typically occurs when more than 90-99% of the population has lost viability. This phenotype is often associated with increased oxidative stress and/or decreased protection in the cell. For example, the frequency of this phenotype more than doubles in cells lacking cytosolic superoxide dismutase and greatly reduces in long-lived mutants (e.g., sch9Δ or ras2Δ) or mutants overexpressing superoxide dismutases22. In practice, we define regrowth as an increase in viability or stabilization in viability for 3 consecutive samplings in the high mortality phase during chronological aging.

    Age-dependent frequencies of different DNA mutations vary greatly depending on the strain background, genetic manipulation, culture conditions, as well as regrowth/gasping and extremely low survival. Pre-experiments should be carried out at time points such as the mean and maximum survival with various plating density for mutation assays to determine mutation frequency range before performingthe full scale life span analysis. The wild type strain should always be included in a life span or mutation frequency study in parallel to any treatment or genetic mutant, such that inter-experiment-variations can be accounted for. Multiple biological replicas should be included in the study; and, both liquid and in situ viability/mutation assays should be carried out to corroborate the results.

    Instead of focusing on one specific type of DNA mutation, profiling of age-dependent genomic instability using multiple assays in combination, may shed light on specific DNA damage and DNA damage repair system(s) that contribute to age-dependant genomic instability. For example, a significant increase in gross chromosomal rearrangements (GCRs), compared to those of other DNA mutations, is observed in wild type yeast suggesting an elevationof double strand break and/or an impairment in non-homologous end joining (NHEJ) during yeast chronological aging (Table 2). The can1 mutation spectrum (sequencing of the CAN1 gene) obtained in the wild-type aging yeast suggested an increase in oxidative damage during chronological aging and error-prone DNA repair; whereas, in long-lived sch9Δ mutants, less oxidative DNA damage and much reduced error-prone translesion synthesis were observed20.

    Methods described here can be further expended to study age-dependant genomic instability. For example, quiescent and non-quiescent cells can be isolated from yeast stationary-phase cultures using the density gradient method described by Allen et al.23. Combined with the mutation assays described here, we have reported that a large portion of age-dependent mutations arises from quiescent cells, rather than the dividing, damaged or apoptotic cells20,24.


    No conflicts of interest declared.


    We thank S. Jinks Robertson and E. Heidenreich for providing plasmids and yeast strains; P. Pham and M.F. Goodman for help withthe TLS assay. This work was supported, in part, by the American Federation for Aging Research grant and by NIH AG20642, AG025135.


    1. Longo, V. D., Finch, C. E. Evolutionary medicine: from dwarf model systems to healthy centenarians. Science. 299, 1342-1346 (2003).
    2. Fontana, L., Partridge, L., Longo, V. D. Extending healthy life span--from yeast to humans. Science. 328, 321-326 (2010).
    3. Mortimer, R. K., Johnston, J. R. Life span of individual yeast cells. Nature. 183, 1751-1752 (1959).
    4. Muller, I., Zimmermann, M., Becker, D., Flomer, M. Calendar life span versus budding life span of Saccharomyces cerevisiae. Mech. Ageing Dev. 12, 47-52 (1980).
    5. Jazwinski, S. M., Egilmez, N. K., Chen, J. B. Replication control and cellular life span. Exp. Gerontol. 24, 423-436 (1989).
    6. Pohley, H. J. A formal mortality analysis for populations of unicellular organisms (Saccharomyces cerevisiae. Mech Ageing Dev. 38, 231-243 (1987).
    7. Longo, V. D., Gralla, E. B., Valentine, J. S. Superoxide dismutase activity is essential for stationary phase survival in Saccharomyces cerevisiae. Mitochondrial production of toxic oxygen species in vivo. J Biol Chem. 271, 12275-12280 (1996).
    8. Longo, V. The chronological life span of Saccharomyces cerevisiae. Studies of superoxide dismutase, Ras and Bcl-2 [dissertation]. University of California Los Angeles California Los Angeles (1997).
    9. Fabrizio, P., Pozza, F., Pletcher, S. D., Gendron, C. M., Longo, V. D. Regulation of longevity and stress resistance by Sch9 in yeast. Science. 292, 288-290 (2001).
    10. Fabrizio, P., Longo, V. D. The chronological life span of Saccharomyces cerevisiae. Aging Cell. 2, 73-81 (2003).
    11. Madia, F., Gattazzo, C., Fabrizio, P., Longo, V. D. A simple model system for age-dependent DNA damage and cancer. Mech Ageing Dev. 128, 45-49 (2007).
    12. Wei, M. Life span extension by calorie restriction depends on Rim15 and transcription factors downstream of Ras/PKA, Tor, and Sch9. PLoS Genet. 4, e13-e13 (2008).
    13. Fabrizio, P. Superoxide is a mediator of an altruistic aging program in Saccharomyces cerevisiae. J Cell Biol. 166, 1055-1067 (2004).
    14. Wei, M. Tor1/Sch9-regulated carbon source substitution is as effective as calorie restriction in life span extension. PLoS Genet. 5, e1000467-e1000467 (2009).
    15. Capizzi, R. L., Jameson, J. W. A table for the estimation of the spontaneous mutation rate of cells in culture. Mutat Res. 17, 147-148 (1973).
    16. Heidenreich, E., Novotny, R., Kneidinger, B., Holzmann, V., Wintersberger, U. Non-homologous end joining as an important mutagenic process in cell cycle-arrested cells. Embo J. 22, 2274-2283 (2003).
    17. Heidenreich, E., Wintersberger, U. Replication-dependent and selection-induced mutations in respiration-competent and respiration-deficient strains of Saccharomyces cerevisiae. Mol Gen Genet. 260, 395-400 (1998).
    18. Chen, C., Kolodner, R. D. Gross chromosomal rearrangements in Saccharomyces cerevisiae replication and recombination defective mutants. Nat Genet. 23, 81-85 (1999).
    19. Datta, A., Adjiri, A., New, L., Crouse, G. F., JinksRobertson, S. Mitotic crossovers between diverged sequences are regulated by mismatch repair proteins in Saccaromyces cerevisiae. Mol Cell Biol. 16, 1085-1093 (1996).
    20. Madia, F. Oncogene homologue Sch9 promotes age-dependent mutations by a superoxide and Rev1/Polzeta-dependent mechanism. J Cell Biol. 186, 509-523 (2009).
    21. Wang, Z. Controlled expression of recombinant genes and preparation of cell-free extracts in yeast. Methods Mol Biol. 313, 317-331 (2006).
    22. Fabrizio, P., Pletcher, S. D., Minois, N., Vaupel, J. W., Longo, V. D. Chronological aging-independent replicative life span regulation by Msn2/Msn4 and Sod2 in Saccharomyces cerevisiae. FEBS Lett. 557, 136-142 (2004).
    23. Allen, C. Isolation of quiescent and nonquiescent cells from yeast stationary-phase cultures. J Cell Biol. 174, 89-100 (2006).
    24. Madia, F. Longevity mutation in SCH9 prevents recombination errors and premature genomic instability in a Werner/Bloom model system. J Cell Biol. 180, 67-81 (2008).



    Post a Question / Comment / Request

    You must be signed in to post a comment. Please or create an account.


    simple hit counter